Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma

Abstract The blood-brain barrier (BBB) inhibits the entry of the majority of chemotherapeutic agents into the brain. Previous studies have illustrated the feasibility of drug delivery across the BBB using focused ultrasound (FUS) and microbubbles. Here, we investigated the effect of FUS-enhanced del...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ultrasound in medicine & biology 2012-10, Vol.38 (10), p.1716-1725
Hauptverfasser: Treat, Lisa H, McDannold, Nathan, Zhang, Yongzhi, Vykhodtseva, Natalia, Hynynen, Kullervo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1725
container_issue 10
container_start_page 1716
container_title Ultrasound in medicine & biology
container_volume 38
creator Treat, Lisa H
McDannold, Nathan
Zhang, Yongzhi
Vykhodtseva, Natalia
Hynynen, Kullervo
description Abstract The blood-brain barrier (BBB) inhibits the entry of the majority of chemotherapeutic agents into the brain. Previous studies have illustrated the feasibility of drug delivery across the BBB using focused ultrasound (FUS) and microbubbles. Here, we investigated the effect of FUS-enhanced delivery of doxorubicin on survival in rats with and 9L gliosarcoma cells inoculated in the brain. Each rat received either: (1) no treatment (control; N = 11), (2) FUS only (N = 9), (3) IV liposomal doxorubicin (DOX only; N = 17), or (4) FUS with concurrent IV injections of liposomal doxorubicin (FUS+DOX; N = 20). Post-treatment by magnetic resonance imaging (MRI) showed that FUS+DOX reduced tumor growth compared with DOX only. Further, we observed a modest but significant increase in median survival time after a single treatment FUS+DOX treatment ( p  = 0.0007), whereas neither DOX nor FUS had any significant impact on survival on its own. These results suggest that combined ultrasound-mediated BBB disruption may significantly increase the antineoplastic efficacy of liposomal doxorubicin in the brain.
doi_str_mv 10.1016/j.ultrasmedbio.2012.04.015
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3438387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0301562912002529</els_id><sourcerecordid>1039040417</sourcerecordid><originalsourceid>FETCH-LOGICAL-c638t-fbf55cb5d3ca8623f50681ff28f013d934b69cca797477899fe8e148653726f83</originalsourceid><addsrcrecordid>eNqNks1uEzEUhUcIREPgFZCFhMRmgn9mxh4WlZKmDZGCkEoqsbM8Hrs4zNjBHkfkLfrIdUgohRUrL-45517f72bZGwQnCKLq_WYSu8GL0Ku2MW6CIcITWEwgKp9kI8RoneMafX2ajSCBKC8rXJ9lL0LYQAhpRejz7AxjhhijbJTdLfutdzvVgqkdTL6OvfPgUmslB-A0WJmtC64XHZi7n87HxkhjwVQPyoO18LdqSM5Z51ybz7xIpZnw3qTi3AQft4NxFjR78Ol6mS-iaZP4yskY0nvz6wsu2hYk27UYwKIzqdPL7JkWXVCvTu84u7m6XF98zFefF8uL6SqXFWFDrhtdlrIpWyIFqzDRJawY0hozDRFpa1I0VS2loDUtKGV1rRVTqGBVSSiuNCPj7PyYu41NWqRUNs3T8a03vfB77oThf1es-cZv3Y6TgjDCaAp4dwrw7kdUYeC9CVJ1nbDKxcARJDUsYIEO0g9HqfQuBK_0QxsE-QEp3_DHSPkBKYcFT0iT-fXjQR-svxkmwduTQAQpOu2FlSb80VWkRDStaJzNjzqV1rpLkHiQRlmpWuMTbt4683_znP8TIztjTer8Xe1V2LjobQLHEQ_Jw78cjvBwgwhDiEtck3tTYt3v</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1039040417</pqid></control><display><type>article</type><title>Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Treat, Lisa H ; McDannold, Nathan ; Zhang, Yongzhi ; Vykhodtseva, Natalia ; Hynynen, Kullervo</creator><creatorcontrib>Treat, Lisa H ; McDannold, Nathan ; Zhang, Yongzhi ; Vykhodtseva, Natalia ; Hynynen, Kullervo</creatorcontrib><description>Abstract The blood-brain barrier (BBB) inhibits the entry of the majority of chemotherapeutic agents into the brain. Previous studies have illustrated the feasibility of drug delivery across the BBB using focused ultrasound (FUS) and microbubbles. Here, we investigated the effect of FUS-enhanced delivery of doxorubicin on survival in rats with and 9L gliosarcoma cells inoculated in the brain. Each rat received either: (1) no treatment (control; N = 11), (2) FUS only (N = 9), (3) IV liposomal doxorubicin (DOX only; N = 17), or (4) FUS with concurrent IV injections of liposomal doxorubicin (FUS+DOX; N = 20). Post-treatment by magnetic resonance imaging (MRI) showed that FUS+DOX reduced tumor growth compared with DOX only. Further, we observed a modest but significant increase in median survival time after a single treatment FUS+DOX treatment ( p  = 0.0007), whereas neither DOX nor FUS had any significant impact on survival on its own. These results suggest that combined ultrasound-mediated BBB disruption may significantly increase the antineoplastic efficacy of liposomal doxorubicin in the brain.</description><identifier>ISSN: 0301-5629</identifier><identifier>EISSN: 1879-291X</identifier><identifier>DOI: 10.1016/j.ultrasmedbio.2012.04.015</identifier><identifier>PMID: 22818878</identifier><identifier>CODEN: USMBA3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>9L gliosarcoma ; Animals ; Antineoplastic Agents - administration &amp; dosage ; Biological and medical sciences ; Blood-brain barrier ; Blood-Brain Barrier - radiation effects ; Brain Neoplasms - diagnosis ; Brain Neoplasms - drug therapy ; Brain Neoplasms - physiopathology ; Cell Line, Tumor ; Doxorubicin ; Doxorubicin - administration &amp; dosage ; Focused ultrasound ; Gliosarcoma - diagnosis ; Gliosarcoma - drug therapy ; Gliosarcoma - physiopathology ; Investigative techniques, diagnostic techniques (general aspects) ; Liposomes - administration &amp; dosage ; Liposomes - chemistry ; Magnetic Resonance Imaging, Interventional - methods ; Male ; Medical sciences ; Microbubbles - therapeutic use ; Neurology ; Radiology ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Rats ; Rats, Sprague-Dawley ; Sonication - methods ; Survival ; Treatment Outcome ; Tumors of the nervous system. Phacomatoses</subject><ispartof>Ultrasound in medicine &amp; biology, 2012-10, Vol.38 (10), p.1716-1725</ispartof><rights>World Federation for Ultrasound in Medicine &amp; Biology</rights><rights>2012 World Federation for Ultrasound in Medicine &amp; Biology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 World Federation for Ultrasound in Medicine &amp; Biology. Published by Elsevier Inc. All rights reserved.</rights><rights>2012 World Federation for Ultrasound in Medicine and Biology. Published by Elsevier Inc. All rights reserved. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c638t-fbf55cb5d3ca8623f50681ff28f013d934b69cca797477899fe8e148653726f83</citedby><cites>FETCH-LOGICAL-c638t-fbf55cb5d3ca8623f50681ff28f013d934b69cca797477899fe8e148653726f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0301562912002529$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26351762$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22818878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Treat, Lisa H</creatorcontrib><creatorcontrib>McDannold, Nathan</creatorcontrib><creatorcontrib>Zhang, Yongzhi</creatorcontrib><creatorcontrib>Vykhodtseva, Natalia</creatorcontrib><creatorcontrib>Hynynen, Kullervo</creatorcontrib><title>Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma</title><title>Ultrasound in medicine &amp; biology</title><addtitle>Ultrasound Med Biol</addtitle><description>Abstract The blood-brain barrier (BBB) inhibits the entry of the majority of chemotherapeutic agents into the brain. Previous studies have illustrated the feasibility of drug delivery across the BBB using focused ultrasound (FUS) and microbubbles. Here, we investigated the effect of FUS-enhanced delivery of doxorubicin on survival in rats with and 9L gliosarcoma cells inoculated in the brain. Each rat received either: (1) no treatment (control; N = 11), (2) FUS only (N = 9), (3) IV liposomal doxorubicin (DOX only; N = 17), or (4) FUS with concurrent IV injections of liposomal doxorubicin (FUS+DOX; N = 20). Post-treatment by magnetic resonance imaging (MRI) showed that FUS+DOX reduced tumor growth compared with DOX only. Further, we observed a modest but significant increase in median survival time after a single treatment FUS+DOX treatment ( p  = 0.0007), whereas neither DOX nor FUS had any significant impact on survival on its own. These results suggest that combined ultrasound-mediated BBB disruption may significantly increase the antineoplastic efficacy of liposomal doxorubicin in the brain.</description><subject>9L gliosarcoma</subject><subject>Animals</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Blood-brain barrier</subject><subject>Blood-Brain Barrier - radiation effects</subject><subject>Brain Neoplasms - diagnosis</subject><subject>Brain Neoplasms - drug therapy</subject><subject>Brain Neoplasms - physiopathology</subject><subject>Cell Line, Tumor</subject><subject>Doxorubicin</subject><subject>Doxorubicin - administration &amp; dosage</subject><subject>Focused ultrasound</subject><subject>Gliosarcoma - diagnosis</subject><subject>Gliosarcoma - drug therapy</subject><subject>Gliosarcoma - physiopathology</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Liposomes - administration &amp; dosage</subject><subject>Liposomes - chemistry</subject><subject>Magnetic Resonance Imaging, Interventional - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbubbles - therapeutic use</subject><subject>Neurology</subject><subject>Radiology</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sonication - methods</subject><subject>Survival</subject><subject>Treatment Outcome</subject><subject>Tumors of the nervous system. Phacomatoses</subject><issn>0301-5629</issn><issn>1879-291X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks1uEzEUhUcIREPgFZCFhMRmgn9mxh4WlZKmDZGCkEoqsbM8Hrs4zNjBHkfkLfrIdUgohRUrL-45517f72bZGwQnCKLq_WYSu8GL0Ku2MW6CIcITWEwgKp9kI8RoneMafX2ajSCBKC8rXJ9lL0LYQAhpRejz7AxjhhijbJTdLfutdzvVgqkdTL6OvfPgUmslB-A0WJmtC64XHZi7n87HxkhjwVQPyoO18LdqSM5Z51ybz7xIpZnw3qTi3AQft4NxFjR78Ol6mS-iaZP4yskY0nvz6wsu2hYk27UYwKIzqdPL7JkWXVCvTu84u7m6XF98zFefF8uL6SqXFWFDrhtdlrIpWyIFqzDRJawY0hozDRFpa1I0VS2loDUtKGV1rRVTqGBVSSiuNCPj7PyYu41NWqRUNs3T8a03vfB77oThf1es-cZv3Y6TgjDCaAp4dwrw7kdUYeC9CVJ1nbDKxcARJDUsYIEO0g9HqfQuBK_0QxsE-QEp3_DHSPkBKYcFT0iT-fXjQR-svxkmwduTQAQpOu2FlSb80VWkRDStaJzNjzqV1rpLkHiQRlmpWuMTbt4683_znP8TIztjTer8Xe1V2LjobQLHEQ_Jw78cjvBwgwhDiEtck3tTYt3v</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Treat, Lisa H</creator><creator>McDannold, Nathan</creator><creator>Zhang, Yongzhi</creator><creator>Vykhodtseva, Natalia</creator><creator>Hynynen, Kullervo</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20121001</creationdate><title>Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma</title><author>Treat, Lisa H ; McDannold, Nathan ; Zhang, Yongzhi ; Vykhodtseva, Natalia ; Hynynen, Kullervo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c638t-fbf55cb5d3ca8623f50681ff28f013d934b69cca797477899fe8e148653726f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>9L gliosarcoma</topic><topic>Animals</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Blood-brain barrier</topic><topic>Blood-Brain Barrier - radiation effects</topic><topic>Brain Neoplasms - diagnosis</topic><topic>Brain Neoplasms - drug therapy</topic><topic>Brain Neoplasms - physiopathology</topic><topic>Cell Line, Tumor</topic><topic>Doxorubicin</topic><topic>Doxorubicin - administration &amp; dosage</topic><topic>Focused ultrasound</topic><topic>Gliosarcoma - diagnosis</topic><topic>Gliosarcoma - drug therapy</topic><topic>Gliosarcoma - physiopathology</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Liposomes - administration &amp; dosage</topic><topic>Liposomes - chemistry</topic><topic>Magnetic Resonance Imaging, Interventional - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbubbles - therapeutic use</topic><topic>Neurology</topic><topic>Radiology</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sonication - methods</topic><topic>Survival</topic><topic>Treatment Outcome</topic><topic>Tumors of the nervous system. Phacomatoses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Treat, Lisa H</creatorcontrib><creatorcontrib>McDannold, Nathan</creatorcontrib><creatorcontrib>Zhang, Yongzhi</creatorcontrib><creatorcontrib>Vykhodtseva, Natalia</creatorcontrib><creatorcontrib>Hynynen, Kullervo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Ultrasound in medicine &amp; biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Treat, Lisa H</au><au>McDannold, Nathan</au><au>Zhang, Yongzhi</au><au>Vykhodtseva, Natalia</au><au>Hynynen, Kullervo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma</atitle><jtitle>Ultrasound in medicine &amp; biology</jtitle><addtitle>Ultrasound Med Biol</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>38</volume><issue>10</issue><spage>1716</spage><epage>1725</epage><pages>1716-1725</pages><issn>0301-5629</issn><eissn>1879-291X</eissn><coden>USMBA3</coden><abstract>Abstract The blood-brain barrier (BBB) inhibits the entry of the majority of chemotherapeutic agents into the brain. Previous studies have illustrated the feasibility of drug delivery across the BBB using focused ultrasound (FUS) and microbubbles. Here, we investigated the effect of FUS-enhanced delivery of doxorubicin on survival in rats with and 9L gliosarcoma cells inoculated in the brain. Each rat received either: (1) no treatment (control; N = 11), (2) FUS only (N = 9), (3) IV liposomal doxorubicin (DOX only; N = 17), or (4) FUS with concurrent IV injections of liposomal doxorubicin (FUS+DOX; N = 20). Post-treatment by magnetic resonance imaging (MRI) showed that FUS+DOX reduced tumor growth compared with DOX only. Further, we observed a modest but significant increase in median survival time after a single treatment FUS+DOX treatment ( p  = 0.0007), whereas neither DOX nor FUS had any significant impact on survival on its own. These results suggest that combined ultrasound-mediated BBB disruption may significantly increase the antineoplastic efficacy of liposomal doxorubicin in the brain.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22818878</pmid><doi>10.1016/j.ultrasmedbio.2012.04.015</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0301-5629
ispartof Ultrasound in medicine & biology, 2012-10, Vol.38 (10), p.1716-1725
issn 0301-5629
1879-291X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3438387
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 9L gliosarcoma
Animals
Antineoplastic Agents - administration & dosage
Biological and medical sciences
Blood-brain barrier
Blood-Brain Barrier - radiation effects
Brain Neoplasms - diagnosis
Brain Neoplasms - drug therapy
Brain Neoplasms - physiopathology
Cell Line, Tumor
Doxorubicin
Doxorubicin - administration & dosage
Focused ultrasound
Gliosarcoma - diagnosis
Gliosarcoma - drug therapy
Gliosarcoma - physiopathology
Investigative techniques, diagnostic techniques (general aspects)
Liposomes - administration & dosage
Liposomes - chemistry
Magnetic Resonance Imaging, Interventional - methods
Male
Medical sciences
Microbubbles - therapeutic use
Neurology
Radiology
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Rats
Rats, Sprague-Dawley
Sonication - methods
Survival
Treatment Outcome
Tumors of the nervous system. Phacomatoses
title Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T16%3A54%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20Anti-Tumor%20Effect%20of%20Liposomal%20Doxorubicin%20After%20Targeted%20Blood-Brain%20Barrier%20Disruption%20by%20MRI-Guided%20Focused%20Ultrasound%20in%20Rat%20Glioma&rft.jtitle=Ultrasound%20in%20medicine%20&%20biology&rft.au=Treat,%20Lisa%20H&rft.date=2012-10-01&rft.volume=38&rft.issue=10&rft.spage=1716&rft.epage=1725&rft.pages=1716-1725&rft.issn=0301-5629&rft.eissn=1879-291X&rft.coden=USMBA3&rft_id=info:doi/10.1016/j.ultrasmedbio.2012.04.015&rft_dat=%3Cproquest_pubme%3E1039040417%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1039040417&rft_id=info:pmid/22818878&rft_els_id=1_s2_0_S0301562912002529&rfr_iscdi=true